A survey of 1,102 US men found that only 20% were aware research has linked dairy consumption to increased prostate cancer risk, and that 66% would consider avoiding dairy after learning about it.
The survey was conducted by Morning Consult for the Physicians Committee for Responsible Medicine and released September 13, 2026. Also reported: 20% had received nutrition information about prostate cancer from a healthcare professional, and 76% supported warning labels on dairy products.
Who commissioned it, and why that matters
The Physicians Committee for Responsible Medicine is an advocacy organisation that promotes plant-based diets. That is its stated purpose rather than a hidden agenda, and it is essential context for reading these figures.
A survey measuring awareness of a claim, commissioned by a group that wants the claim more widely known, is a legitimate instrument producing a real number — and it is also a communications exercise. The finding that 76% support warning labels is not an incidental observation; it is the policy the sponsor advocates, tested for public support.
The release states no limitations, which is itself a signal. Independent research almost always does.
What the underlying evidence says
The association is real and is stronger than many nutritional claims. A meta-analysis of 32 studies found elevated risk with higher dairy consumption. One study reported a 19% increased risk with daily skim or low-fat milk versus rare consumption. Another, following 3,612 men for eight to ten years, found those consuming around three daily low-fat dairy servings were more than twice as likely to develop prostate cancer as those consuming under one.
An analysis of 11 studies covering more than 700,000 participants found whole-milk consumers faced prostate cancer death risk up to 50% higher than minimal consumers.
Plant-based comparisons point the same way: the Adventist Health Study-2 found vegans had 35% lower prostate cancer risk, and among more than 2,000 men already diagnosed, higher plant-food consumption was associated with 56% lower risk of progression and 59% lower risk of recurrence.
What those numbers do not settle
Every study cited is observational, which in nutrition carries specific problems rather than a generic caveat.
Detection bias is the sharpest here. Prostate cancer is unusual in that a large reservoir of it exists undiagnosed — autopsy studies find it in a substantial share of older men who died of other causes. How much is found therefore depends heavily on how much screening is done, and men who differ in diet also differ in how often they see doctors and request PSA tests.
An apparent association with dairy could partly reflect who gets tested rather than who gets cancer.
Confounding is the other issue. Dairy consumption correlates with overall dietary pattern, body weight, physical activity and income. The Adventist comparison illustrates this plainly: vegans in that cohort differ from non-vegetarians in smoking, alcohol, exercise and body weight, not only in dairy.
The progression and recurrence figures come from men already diagnosed, where reverse causation is a live concern — people whose cancer is behaving aggressively may change how they eat.
The mechanisms proposed
Two are usually offered. Dairy raises circulating IGF-1, a growth factor associated with several cancers in observational data. And high calcium intake suppresses activation of vitamin D, which has been proposed as protective against prostate cancer.
Both are plausible and neither is established as operating at dietary intakes in humans.
How to read it
“Physicians and other healthcare professionals need more education on the dangers of dairy products and the benefits of a plant-based diet for prostate cancer,” said Noah Praamsma, MS, RDN, nutrition coordinator at the Physicians Committee.
The defensible version of this story is narrower than the framing suggests: an association between dairy and prostate cancer appears consistently across observational studies, the mechanisms are plausible, and the evidence has not established causation.
Major cancer organisations do not currently advise men to avoid dairy for prostate cancer prevention, and the gap between that position and this campaign is the actual subject.
What actually reduces prostate cancer risk
Setting the dairy question aside, it is worth stating what the evidence supports more firmly, since the survey found most men get no nutrition guidance from a clinician at all.
The strongest risk factors are not dietary and not modifiable: age, family history, and ancestry — men of African descent face substantially higher incidence and mortality. Inherited mutations in DNA-repair genes raise risk considerably in a small subset.
Among modifiable factors, obesity has the most consistent evidence, and specifically for aggressive rather than indolent disease. Smoking is associated with worse outcomes after diagnosis.
The dietary evidence generally is weaker than public discussion implies. Tomatoes and lycopene, selenium, vitamin E and various supplements have all been proposed and have not held up — a large trial of selenium and vitamin E was stopped after finding no benefit, with a signal of increased risk in one arm.
The practical implication is that the survey identifies a real gap and possibly the wrong remedy. Men who receive no nutrition counselling are underserved; directing that counselling toward a single contested food, rather than toward weight and the screening conversation, would not be the highest-value use of it.
General information, not medical or dietary advice. Discuss prostate cancer risk and screening with your doctor.